Trevi Therapeutics, Inc. (TRVI) Form 8-K Material Events
Trevi Therapeutics, Inc. (TRVI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TRVI
CIK: 1563880
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerChiara Ciraldo
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-17 | 2026-09-15 | 4 | 0001193125-26-394456 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009512 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001193125-26-338071 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338023 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-337974 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002184 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001193125-26-257488 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001193125-26-257365 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001193125-26-257370 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001193125-26-257373 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001193125-26-257371 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-03 | 4 | 0001193125-26-257366 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-07 | — | SCHEDULE 13D/A Filing | 0001072613-26-000382 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001314 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001193125-26-206390 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | 8-K | 0001193125-26-206382 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-21 | 2026-04-21 | DEF 14A | 0001193125-26-166695 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-21 | — | DEFA14A | 0001193125-26-166693 | View SEC Doc Filr Page |
| ARS | 2026-04-21 | 2025-12-31 | ARS | 0001193125-26-166694 | View SEC Doc Filr Page |
| 424B5 | 2026-04-17 | — | 424B5 | 0001193125-26-161582 | View SEC Doc Filr Page |
| 8-K | 2026-04-17 | 2026-04-16 | 8-K | 0001193125-26-160355 | View SEC Doc Filr Page |
| 424B5 | 2026-04-16 | — | 424B5 | 0001193125-26-159041 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-10 | 2026-04-10 | PRE 14A | 0001193125-26-151354 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-27 | — | SCHEDULE 13G/A Filing | 0000102909-26-002401 | View SEC Doc Filr Page |
| 10-K | 2026-03-17 | 2025-12-31 | 10-K | 0001193125-26-110783 | View SEC Doc Filr Page |